BANK OF NOVA SCOTIA - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.

Quarter-by-quarter ownership
BANK OF NOVA SCOTIA ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$23,183,000
+55.0%
1,000,261
+6.4%
0.13%
+64.9%
Q1 2018$14,959,000
-51.4%
940,478
-36.5%
0.08%
-45.0%
Q4 2017$30,768,000
+125.6%
1,480,635
+55.6%
0.14%
+77.2%
Q3 2017$13,637,000
-33.2%
951,735
-19.0%
0.08%
-26.2%
Q2 2017$20,401,000
+46.5%
1,175,064
-6.8%
0.11%
+81.4%
Q1 2017$13,922,000
+45.7%
1,261,018
+89.7%
0.06%
+20.4%
Q4 2016$9,554,000
-34.8%
664,677
+11.1%
0.05%
-41.0%
Q3 2016$14,662,000
-11.3%
598,020
-27.1%
0.08%
-14.4%
Q2 2016$16,534,000
-10.2%
820,367
+17.0%
0.10%
-14.9%
Q1 2016$18,422,000
-78.6%
701,041
-17.3%
0.11%
-74.2%
Q4 2015$86,126,000
-52.6%
848,041
-16.6%
0.44%
-55.1%
Q3 2015$181,738,000
-37.6%
1,017,299
-22.5%
0.98%
-32.1%
Q2 2015$291,288,000
+3.1%
1,312,820
-8.2%
1.45%
+14.6%
Q1 2015$282,469,000
+38.2%
1,429,399
+0.2%
1.26%
+61.2%
Q4 2014$204,336,000
+5.1%
1,426,705
-3.9%
0.78%
-0.6%
Q3 2014$194,462,000
+22.5%
1,483,968
+18.3%
0.79%
+21.6%
Q2 2014$158,707,000
-4.6%
1,254,858
-0.7%
0.65%
-6.1%
Q1 2014$166,298,000
+11.0%
1,263,858
-1.0%
0.69%
+9.3%
Q4 2013$149,784,000
+18.5%
1,276,758
+5.3%
0.63%
-1.9%
Q3 2013$126,420,000
+24.6%
1,212,158
+3.1%
0.64%
+24.8%
Q2 2013$101,438,000
+27.0%
1,175,862
+10.5%
0.52%
+35.1%
Q1 2013$79,885,0001,064,1930.38%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders